American Cancer Society and Guardant Health Partner to Boost Cancer Screening Access and Health Equity
PorAinvest
lunes, 4 de agosto de 2025, 8:09 am ET1 min de lectura
GH--
The partnership is designed to increase awareness, promote early detection, and improve outcomes for individuals in communities with limited access to preventive care. According to ACS, despite being a hub of healthcare innovation, California continues to lag behind the national average in key cancer screening rates. Data from ACS shows that only 64% of California women aged 45 and older are up to date on screening mammograms, compared to 69% nationally. Colorectal cancer screening rates are also lower, with 60% of eligible Californians screened compared to 62% nationwide [1].
Guardant Health will support ACS initiatives such as expanding the reach of the "I Love You, Get Screened" campaign, which garnered over 313 million impressions in 2024 and delivers culturally relevant education to communities including Black/African American, Hispanic/Latino, and LGBTQ+ populations. The company will also promote digital tools on cancer.org, including a locator tool that helps individuals find more than 15,000 screening locations across the U.S. Additionally, Guardant Health will support community health interventions such as patient education, navigation to screening appointments, transportation support, and language access services [1].
Throughout 2025, ACS will engage communities across the nation through impactful campaigns aligned with key cancer awareness months—including cervical cancer awareness in January, colorectal in March, prostate in September, breast in October, and lung in November. These efforts will feature personal stories, local events, and trusted education to empower more people to get screened and take charge of their health.
The partnership underscores the commitment of both organizations to ensuring that everyone, regardless of race, ethnicity, income, or ZIP code, has access to convenient and timely cancer screening, so they can detect cancer earlier and have a better chance of survival.
References:
[1] https://www.businesswire.com/news/home/20250804054617/en/American-Cancer-Society-and-Guardant-Health-Partner-to-Expand-Cancer-Screening-Access-and-Advance-Health-Equity
[2] https://www.stocktitan.net/news/GH/american-cancer-society-and-guardant-health-partner-to-expand-cancer-ihoiba2xmmyw.html
The American Cancer Society and Guardant Health have partnered to expand cancer screening access and advance health equity. The partnership supports ACS's nationwide cancer screening efforts, including community-based health system partnerships and state coalition work. Guardant Health will support ACS initiatives such as expanding the reach of the "I Love You, Get Screened" campaign and promoting digital tools on cancer.org. The goal is to increase awareness, promote early detection, and improve outcomes for individuals in communities with limited access to preventive care.
The American Cancer Society (ACS) and Guardant Health have formed a strategic partnership to enhance cancer screening access and promote health equity. The collaboration aims to support ACS's nationwide cancer screening efforts, including community-based health system partnerships and state coalition work. Guardant Health will contribute by expanding the reach of the "I Love You, Get Screened" campaign and promoting digital tools on cancer.org.The partnership is designed to increase awareness, promote early detection, and improve outcomes for individuals in communities with limited access to preventive care. According to ACS, despite being a hub of healthcare innovation, California continues to lag behind the national average in key cancer screening rates. Data from ACS shows that only 64% of California women aged 45 and older are up to date on screening mammograms, compared to 69% nationally. Colorectal cancer screening rates are also lower, with 60% of eligible Californians screened compared to 62% nationwide [1].
Guardant Health will support ACS initiatives such as expanding the reach of the "I Love You, Get Screened" campaign, which garnered over 313 million impressions in 2024 and delivers culturally relevant education to communities including Black/African American, Hispanic/Latino, and LGBTQ+ populations. The company will also promote digital tools on cancer.org, including a locator tool that helps individuals find more than 15,000 screening locations across the U.S. Additionally, Guardant Health will support community health interventions such as patient education, navigation to screening appointments, transportation support, and language access services [1].
Throughout 2025, ACS will engage communities across the nation through impactful campaigns aligned with key cancer awareness months—including cervical cancer awareness in January, colorectal in March, prostate in September, breast in October, and lung in November. These efforts will feature personal stories, local events, and trusted education to empower more people to get screened and take charge of their health.
The partnership underscores the commitment of both organizations to ensuring that everyone, regardless of race, ethnicity, income, or ZIP code, has access to convenient and timely cancer screening, so they can detect cancer earlier and have a better chance of survival.
References:
[1] https://www.businesswire.com/news/home/20250804054617/en/American-Cancer-Society-and-Guardant-Health-Partner-to-Expand-Cancer-Screening-Access-and-Advance-Health-Equity
[2] https://www.stocktitan.net/news/GH/american-cancer-society-and-guardant-health-partner-to-expand-cancer-ihoiba2xmmyw.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios